RESEARCH PAPER
Comparative study on usefulness of gentamycin-containing collagen implants in the treatment of patients with osteitis and osteomyelitis of the craniofacial skeleton
 
More details
Hide details
1
Clinic of Cranio-Maxillo-Facial and Oral Surgery and Implantology, Medical University of Warsaw, Warsaw, Poland
2
Department of Orthodontics, Medical University of Warsaw, Warsaw, Poland
3
Department of Pharmaceutical Microbiology, Medical University of Warsaw, Warsaw, Poland
4
Department of Medical Biology, Medical University of Warsaw, Warsaw, Poland
CORRESPONDING AUTHOR
Paweł J. Zawadzki   

Clinic of Cranio-Maxillo-Facial and Oral Surgery and Implantology, Medical University of Warsaw, Warsaw, Poland
 
Ann Agric Environ Med. 2017;24(2):299–302
KEYWORDS
ABSTRACT
Introduction and objective:
A reduction in incidences of peri-surgical complications due to infections is achieved by antibiotic prophylaxis The objective of the study was to assess the usefulness of gentamycin-containing collagen implants (GCCI) in the treatment of patients with osteitis and osteomyelitis of the craniofacial skeleton.

Material and Methods:
The retrospective study included 103 patients with osteitis and osteomyelitis. 54 patients were treated intra-operatively with GCCI (Garamycin, EusaPharma, Europe). 49 patients were treated according to standard procedures. Light microscopy and in vitro culture techniques were applied for bacteria specific identification, and to investigate the resistance of detected microbiota to antibiotics. Patients received one dose of antibiotic pre-operatively. Post-operative antibiotic treatment was administered individually, according to clinical course and microbiological tests. The patients were followed-up on days 3, 7 and 14 after discharge for local complications; radiographic follow-up was performed 3, 6 and 12 months after surgery.

Results:
The course of post-operative antibiotic therapy was shorter in GCCI patients than in the control group (median 1 vs. 7 days); they also required shorter hospitalization (median 3 vs. 4 days). Implantation of GCCI significantly reduced the incidence of local complications (OR 0.30, 95%CI 0.11–0.83, p<0.0001), independently of the use of postoperative antibiotic therapy. On follow-up after 3–12 months, all patients presented with good soft tissue and bone healing.

Conclusions:
The results of this comparative study advocate the use of GCCI in osteomyelitis of various origin in oral and maxillofacial surgery, as they seemed to reduce the incidence of local complications, shorten antibiotic administration time and hospital stay.

 
REFERENCES (25)
1.
Goda A, Maruyama F, Michi Y, Nakagawa I, Harada K. Analysis of the factors affecting the formation of the microbiome associated with chronic osteomyelitis of the jaw. Clin Microbiol Infect 2014; 20(5): 0309–0317.
 
2.
Hussain ST. Local application of gentamicin-containing collagen implant in the prophylaxis and treatment of surgical site infection following vascular surgery. Int J Surg. 2012; 10: S5-S9.
 
3.
de Bruin AF, Gosselink MP, van der Harst E. Local application of gentamicin-containing collagen implant in the prophylaxis of surgical site infection following gastrointestinal surgery. Int J Surg. 2012; 10: S21-S27.
 
4.
Raja SG. Local application of gentamicin-containing collagen implant in the prophylaxis and treatment of surgical site infection following cardiac surgery. Int J Surg. 2012; 10: S10-S14.
 
5.
Friberg O, Svedjeholm R, Soderquist B, Granfeldt H, Vikerfors T, Kallman J. Local gentamicin reduces sternal wound infections after cardiac surgery: a randomized controlled trial. Ann Thorac Surg. 2005; 79: 153–161.
 
6.
Knaepler H. Local application of gentamicin-containing collagen implant in the prophylaxis and treatment of surgical site infection in orthopaedic surgery. Int J Surg. 2012; 10: S15-S20.
 
7.
Murray PR, Baron EJ, Jorgensen JH, Landry ML, Pfaller MA. Manual of clinical microbiology. 9th edition. ASM Press, Washington, USA, 2007.
 
8.
Lovering AM, Sunderland J. Impact of soaking gentamicin-containing collagen implants on potential antimicrobial efficacy. Int J Surg.2012; 10: S2-S4.
 
9.
Parker SJ, Brown D, Hill PF, Watkins PE. Fibrinogen-impregnated collagen as a combined haemostatic agent and antibiotic delivery system in a porcine model of splenic trauma. Eur J Surg. 1999; 165: 609–614.
 
10.
Hussain ST. Local application of gentamicin-containing collagen implant in the prophylaxis and treatment of surgical site infection following vascular surgery. Int J Surg. 2012; 10: S5.
 
11.
Leyh RG, Bartels C, Sievers HH. Adjuvant treatment of deep sternal wound infection with collagenous gentamycin. Ann Thorac Surg. 1999; 68: 1648–1651..
 
12.
de Bruin AF, Gosselink MP, Wijffels NA, Coene PP, van der Harst E: Local gentamicin reduces perineal wound infection after radiotherapy and abdominoperineal resection. Tech Coloproctol. 2008; 12: 303–307.
 
13.
Attmanspacher W, Dittrich V, Schatzler A, Stedtfeld HW: [Mid-term outcome of postoperative infections of the shoulder]. Unfallchirurg. 2000; 10: 1048–056.
 
14.
Conterno LO, Turchi MD. Antibiotics for treating chronic osteomyelitis in adults. Cochrane Database Syst Rev 2013; 6 (9):CD004439. doi: 10.1002/14651858.CD004439.pub3.
 
15.
Moore RD, Smith CR, Lietman PS: The association of aminoglycoside plasma levels with mortality in patients with gram-negative bacteremia. J Infect Dis. 1984; 149: 443–448.
 
16.
Moore RD, Lietman PS, Smith CR: Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration. J Infect Dis. 1987; 155: 93–99.
 
17.
Xiong YQ, Caillon J, Kergueris MF, Drugeon H, Baron D, Potel G, Bayer AS: Adaptive resistance of Pseudomonas aeruginosa induced by aminoglycosides and killing kinetics in a rabbit endocarditis model. Antimicrob Agents Chemother 1997; 4: 823–826.
 
18.
Tam VH, Kabbara S, Vo G, Schilling AN, Coyle EA: Comparative pharmacodynamics of gentamicin against Staphylococcus aureus and Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2006; 50: 2626–2631.
 
19.
Kashuba AD, Bertino JS, Jr., Nafziger AN: Dosing of aminoglycosides to rapidly attain pharmacodynamic goals and hasten therapeutic response by using individualized pharmacokinetic monitoring of patients with pneumonia caused by gram-negative organisms. Antimicrob Agents Chemother. 1998; 42: 1842- 1844.
 
20.
Rutten HJ: Local application of gentamycin-containing collagen implant in the prophylaxis and treatment of surgical site infection. Int J Surg. 2012; 10: S1.
 
21.
Wróblewska M, Strużycka I, Mierzwińska-Nastalska E. Significance of biofilms in dentistry. Przegl. Epidemiol. (Epidemiological Review). 2015; 69: 739–744.
 
22.
Zawadzki PJ, Starościak B, Perkowski K, Baltaza W, Padzik M, Pionkowski K, Chomicz L. et al. Comparative assessment of selected intraoral microorganisms – potential factors for peri-surgical management complications. Annals of Parasit. 2016; 62(3): 233–237.
 
23.
Holck DE, Dutton JJ, Proia A, Khawly J, Mittra R, Dev S, Imami N. Rate of vascularization of coralline hydroxyapatite spherical implants pretreated with saline/gentamicin, rTGF-beta 2, and autogenous plasma. Ophthal Plast Reconstr Surg. 1998; 14: 73–80.
 
24.
Oghli AA, Steveling H: Ridge preservation following tooth extraction: a comparison between atraumatic extraction and socket seal surgery. Quintessence Int. 2010; 41: 605–609.
 
25.
Stavropoulos A, Karring ES, Kostopoulos L, Karring T. Deproteinized bovine bone and gentamicin as an adjunct to GTR in the treatment of intrabony defects: a randomized controlled clinical study. J Clin Periodontol. 2003; 30: 486–495.
 
eISSN:1898-2263
ISSN:1232-1966